Literature DB >> 8603504

Regulation of matrix metalloproteinases and plasminogen activator inhibitor-1 synthesis by plasminogen in cultured human vascular smooth muscle cells.

E Lee1, D E Vaughan, S H Parikh, A J Grodzinsky, P Libby, M W Lark, R T Lee.   

Abstract

Plasmin and matrix metalloproteinases (MMPs) both participate in extracellular matrix remodeling. This study examined the effects of tumor necrosis factor-alpha (TNF-alpha) and plasminogen on collagenase, stromelysin, and plasminogen activator inhibitor-1 (PAI-1) synthesis of collagenase and stromelysin, which remained predominantly in proenzyme forms, as determined by Western analysis of culture media. In contrast, plasminogen and plasmin not only increased secretion of MMPs but also induced cleavage to their active forms. The serine protease inhibitor aprotinin inhibited this activation of MMPs by plasminogen and plasmin. TNF-alpha reduced plasminogen-induced activation of MMPs, suggesting induction of an inhibitor or plasmin generation, such as PAI-1. Enzyme-linked immunosorbent assay of culture media showed that TNF-alpha (10 ng/mL) increased PAI-1 secretion by 4.2 fold compared with control (105.5 +/- 9.6) versus 24.9 +/- 1.7 ng/mL, n = 3). Surprisingly plasminogen also increased PAI-1 secretion by vascular SMCs (3.6-fold over control). These results demonstrate coordination of cytokines and serine proteases in regulating MMP secretion and activation. In addition, the induction of PAI-1 by TNF-alpha and plasminogen suggests a negative feedback mechanisms limit both plasmin-mediated and MMP-mediated matrix degradation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8603504     DOI: 10.1161/01.res.78.1.44

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  16 in total

1.  Matrix metalloproteinases and cardiovascular diseases.

Authors:  A Papazafiropoulou; N Tentolouris
Journal:  Hippokratia       Date:  2009-04       Impact factor: 0.471

2.  Resistance of muscle to tumor metastases: a role for a3 adenosine receptor agonists.

Authors:  S Bar-Yehuda; F Barer; L Volfsson; P Fishman
Journal:  Neoplasia       Date:  2001 Mar-Apr       Impact factor: 5.715

Review 3.  Matrix metalloproteinases in the progression of heart failure: potential therapeutic implications.

Authors:  Y Y Li; A M Feldman
Journal:  Drugs       Date:  2001       Impact factor: 9.546

4.  Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy.

Authors:  Y Y Li; Y Q Feng; T Kadokami; C F McTiernan; R Draviam; S C Watkins; A M Feldman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

5.  Oral administration of muscle derived small molecules inhibits tumor spread while promoting normal cell growth in mice.

Authors:  S Bar-Yehuda; T Farbstein; F Barer; G Ohana; P Fishman
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

Review 6.  Inflammatory and autoimmune reactions in atherosclerosis and vaccine design informatics.

Authors:  Michael Jan; Shu Meng; Natalie C Chen; Jietang Mai; Hong Wang; Xiao-Feng Yang
Journal:  J Biomed Biotechnol       Date:  2010-04-15

7.  In-Vivo Higher Plasma Levels of Platelet-Derived Growth Factor and Matrix Metalloproteinase-9 in Coronary Artery at the Very Onset of Myocardial Infarction with ST-Segment Elevation.

Authors:  Tomomi Koizumi; Nobuyuki Komiyama; Shigeyuki Nishimura
Journal:  Ann Vasc Dis       Date:  2015-09-04

8.  Successful management of tendinopathy with injections of the MMP-inhibitor aprotinin.

Authors:  John Orchard; Andrew Massey; Richard Brown; Adéline Cardon-Dunbar; Jamie Hofmann
Journal:  Clin Orthop Relat Res       Date:  2008-05-01       Impact factor: 4.176

9.  Annexin II incorporated into influenza virus particles supports virus replication by converting plasminogen into plasmin.

Authors:  Fanny LeBouder; Eric Morello; Guus F Rimmelzwaan; Françoise Bosse; Christine Péchoux; Bernard Delmas; Béatrice Riteau
Journal:  J Virol       Date:  2008-04-30       Impact factor: 5.103

10.  The Role of Immunogenicity in Cardiovascular Disease.

Authors:  Michael Jan; Anthony T Virtue; Meghanaben Pansuria; Jingshan Liu; Xinyu Xiong; Pu Fang; Shu Meng; Hong Wang; Xiao-Feng Yang
Journal:  World Heart J       Date:  2011-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.